News

Filter

Current filters:

Amevive

1 to 9 of 75 results

Japan stock market week to April 10, 2006

17-04-2006

Tokyo saw a further advance in the week ended April 10, when the Nikkei 225 rose 0.7% to close at...

AlefaceptAmeviveBiogen IdecCephalonGlaxoSmithKlineGSKKetoprofenModafinilNystatinOralOrudisProvigil

Astellas to acquire Biogen Idec's Amevive

10-04-2006

Japanese drug major Astellas Pharma has agreed to purchase Biogen Idec's Amevive (alefacept), a biologic…

AlefaceptAmeviveAstellas PharmaBiogen Idec

Biogen Idec sees 8% 4th-qtr 2005 sales rise

27-02-2006

The world's third-largest biotechnology firm, Biogen Idec, says that fourth-quarter 2005 revenues reached…

AlefaceptAmeviveAvonexBiogen IdecGenentechIbritumomab TiuxetanInterferon beta-1aNatalizumabRebifRituxanrituximabTysabriZevalin

Biogen Idec to cut 17% of jobs in response to Tysabri

19-09-2005

US biotechnology major Biogen Idec has unveiled plans for restructuring involving the loss of 17% of…

AlefaceptAmeviveAvonexBiogen IdecInterferon beta-1aNatalizumabRituxanrituximabTysabri

Amevive effective in psoriatic arthritis

28-02-2005

Preliminary results from an ongoing double-blind, placebo-controlled Phase II study involving 185 patients…

AlefaceptAmeviveBiogen Idec

Biogen Idec boosted by Avonex

14-02-2005

US biotechnology firm Biogen Idec says it had a "momentous year" and posted strong 2004 results, with…

AlefaceptAmeviveAvonexBiogen IdecGenentechIbritumomab TiuxetanInterferon beta-1aNatalizumabRebifRituxanrituximabTysabriZevalin

1 to 9 of 75 results

COMPANY SPOTLIGHT

Menarini

Back to top